Stay updated with breaking news from Biontech Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
COVID-19 vaccine franchise focused on vaccine adaptation readiness ahead of the fall season and advancing next generation vaccine candidates and combinationsBioNTech and partner OncoC4 plan to start a
Are not sent the registration documents with the access data without being requested to do so, we will be pleased to send them to you on request. 3.Procedure for... | April 13, 2023
Michael Horowicz: Good morning and afternoon. Thank you for joining us today for BioNTech's fourth quarter and full year 2022 earnings call.
Investegate announcements from BioNTech SE, BioNTech Announces Third Quarter 2022 Financial Results and Corporate Update
Second quarter revenues of €3.2 billion1, net profit of €1.7 billion and fully diluted earnings per share of €6.45 ($6.872) as well as first half 2022 revenues of €9.6 billion, net profit of €5.4 billion